Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 3 days agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 4 days agoPharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 3 days agoThe Covid vaccines, a triumph of science and public health, are estimated to have prevented millions...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 3 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 3 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 4 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 4 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 4 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 4 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 4 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...